A Aralex Aachen research explorer

Company ROR OpenAlex

ISA Pharmaceuticals (Netherlands) Sign in to save

33 stored papers · Search its papers → · Its authors →

Papers 33

Therapeutic cancer vaccines
2021 Nature reviews. Cancer review Immunology and Microbiology Immunotherapy and Immune Responses cited by 15 patents

1,576

citations
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival
2020 Science Translational Medicine article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 2 patents

136

citations
Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention
2020 Toxicology Reports article Medicine COVID-19 Clinical Research Studies Open access cited by 1 patent

98

citations
ISA101 and nivolumab for HPV-16 + cancer: updated clinical efficacy and immune correlates of response
2022 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access

98

citations
Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses
2020 Journal for ImmunoTherapy of Cancer article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 1 patent

56

citations
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection
2022 Nature Communications article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 2 patents

54

citations
Peptide emulsions in incomplete Freund’s adjuvant create effective nurseries promoting egress of systemic CD4+ and CD8+ T cells for immunotherapy of cancer
2022 Journal for ImmunoTherapy of Cancer article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 2 patents

42

citations
Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions
2022 Journal for ImmunoTherapy of Cancer article Immunology and Microbiology Immunotherapy and Immune Responses Open access

39

citations
Targeting the PD-1/PD-L1 Axis in Human Vitiligo
2020 Frontiers in Immunology article Biochemistry, Genetics and Molecular Biology melanin and skin pigmentation Open access cited by 1 patent

32

citations
Differential Expression of CD49a and CD49b Determines Localization and Function of Tumor-Infiltrating CD8+ T Cells
2021 Cancer Immunology Research article Medicine Cancer Immunotherapy and Biomarkers Open access

29

citations
IFN‐γ‐induced PD‐L1 expression on human melanocytes is impaired in vitiligo
2021 Experimental Dermatology article Biochemistry, Genetics and Molecular Biology melanin and skin pigmentation Open access

22

citations
Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients
2020 Antiviral Research article Immunology and Microbiology Immunotherapy and Immune Responses Open access

21

citations
Results of a randomized, double-blind, placebo-controlled, phase 2 study (OpcemISA) of the combination of ISA101b and cemiplimab versus cemiplimab for recurrent/metastatic (R/M) HPV16-positive oropharyngeal cancer (OPC).
2024 Journal of Clinical Oncology conference-abstract Medicine Head and Neck Cancer Studies Open access

18

citations
T-Cell Immunotherapy against Mutant KRAS for Pancreatic Cancer
2022 New England Journal of Medicine article Medicine Pancreatic and Hepatic Oncology Research cited by 2 patents

17

citations
Phase 2 study of ISA101b (peltopepimut-S) and cemiplimab in patients with advanced HPV16+ oropharyngeal cancer who failed anti-PD1 therapy.
2023 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers

13

citations
Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV+ Men
2023 Clinical Cancer Research article Medicine Cervical Cancer and HPV Research Open access

11

citations
Special Review: The future of Immunotherapy
2020 Immunotherapy Advances article Medicine Cancer Immunotherapy and Biomarkers Open access

11

citations
Induction of broad multifunctional CD8+ and CD4+ T cells by hepatitis B virus antigen-based synthetic long peptides ex vivo
2023 Frontiers in Immunology article Medicine Hepatitis B Virus Studies Open access cited by 1 patent

10

citations
Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial
2025 Gynecologic Oncology article Medicine Cervical Cancer and HPV Research Open access

10

citations
Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides
2023 Cancer Immunology Immunotherapy article Immunology and Microbiology Immunotherapy and Immune Responses Open access

10

citations

Most cited authors